Key Takeaways
Keybanc initiates coverage on LivaNova (LIVN) with an Overweight rating. New price target set at $81 by Keybanc analyst Brett Fishbin.On D
LIVN: Analyst Initiates Coverage with Overweight Rating and $81 PT
Dec 19, 2025
![i’m-nervous,-too!-[part-2]](https://10xwealthreport.com/wp-content/uploads/2026/03/177042-im-nervous-too-part-2-1568x784.jpg)
